Cadrenal Therapeutics, Inc. (CVKD)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Nov 06, 10:16
Cadrenal Therapeutics Total Assets (Quarterly) : 5.589M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.589M |
| March 31, 2026 | 2.862M |
| December 31, 2025 | 4.327M |
| September 30, 2025 | 4.088M |
| June 30, 2025 | 5.978M |
| March 31, 2025 | 7.953M |
| December 31, 2024 | 10.12M |
| September 30, 2024 | 4.679M |
| June 30, 2024 | 5.457M |
| Date | Value |
|---|---|
| March 31, 2024 | 7.048M |
| December 31, 2023 | 8.519M |
| September 30, 2023 | 9.312M |
| June 30, 2023 | 3.559M |
| March 31, 2023 | 4.482M |
| December 31, 2022 | 0.7782M |
| September 30, 2022 | 0.5453M |
| June 30, 2022 | 0.2433M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.497M |
| Shareholders Equity (Quarterly) | 4.092M |
| Current Ratio | 3.666 |